Glaxo: New product lines will reverse falling sales

Pharmaceutical giant GlaxoSmithKline has said it has a health portfolio of new products in the pipe-line that will reverse their falling sales.

Glaxo: New product lines will reverse falling sales

Pharmaceutical giant GlaxoSmithKline has said it has a health portfolio of new products in the pipe-line that will reverse their falling sales.

Turnover fell by 2% in the three months to the end of 2011, leaving full-year sales down 3% at $43.5bn.

In common with many big players in the industry, Glaxo faces problems inventing new drugs to replace those whose patents have expired.

More in this section

Lunchtime
News Wrap

A lunchtime summary of content highlights on the Irish Examiner website. Delivered at 1pm each day.

Sign up
Revoiced
Newsletter

Our Covid-free newsletter brings together some of the best bits from irishexaminer.com, as chosen by our editor, direct to your inbox every Monday.

Sign up